Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Asia Pacific dental biomaterials market grows at seven percent to 2016

Millennium Research Group : 26 September, 2012  (Company News)
Medical technology market intelligence analyst, Millennium Research Group (MRG), is forecasting that despite the Japanese tsunami's negative effect on market revenues, the Asia Pacific dental biomaterials market will grow moderately at an average annual rate of 6.6 percent through 2016, due to the steady increase in dental implant procedures.


Penetration of biomaterial use with implant and periodontal procedures is still low in the Asia Pacific region in comparison to other global markets, leaving significant room for growth.



South Korea is the largest and most active national market in the Asia Pacific region. Its dentists perform the highest number of dental implant procedures in the region, which increases the demand for dental biomaterials. The market for dental biomaterials in South Korea is fiercely competitive, with many local manufacturers developing lower cost dental biomaterial products, as well as large multinationals providing well-known trusted products. Both Japan and Australia lack such a variety of local competitors in terms of price levels and material makeup and have strict restrictions on the imports of dental biomaterials. Prices in those countries are twice what they are in South Korea. As a result, South Korean dentists are more likely to use the products and gain proficiency in them. As of 2012, South Korea represents approximately 70 percent of dental biomaterials revenues in the region.



Despite the restrictions it places on imports, the relatively underpenetrated Australian market is expected to grow faster than both Japan and South Korea through 2016, as international competitors seek areas of expansion. Nevertheless, Australia will remain the smallest of the three Asia Pacific markets.



"It takes a large initial investment to develop and offer a dental biomaterial product in the Asia Pacific region," said MRG Analyst Carmen Chan. "Regulatory processes are stringent and dentists are hesitant to adopt new products that are unfamiliar to them, which require potential competitors to invest in clinical studies and extensive marketing. As a result, leading competitors are large international companies, particularly Geistlich, which has a strong reputation and trusted relationships with dentists in Australia and South Korea. Geistlich registered in Japan at the end of 2011, and will grow further by entering that underpenetrated market."



Aside from Geistlich, competitors in the Asia Pacific region include Zimmer Dental, Oscotec, Impladent, Straumann and Riemser Arzneimittel.



Millennium Research Group's Asia Pacific Markets for Dental Biomaterials 2012 report includes unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for bone graft substitutes, dental membranes and tissue regeneration products sold in Australia, Japan and South Korea., despite the Japanese tsunami’s negative effect on market revenues, the Asia Pacific dental biomaterials market will grow moderately at an average annual rate of 6.6 percent through 2016, due to the steady increase in dental implant procedures. Penetration of biomaterial use with implant and periodontal procedures is still low in the Asia Pacific region in comparison to other global markets, leaving significant room for growth.



South Korea is the largest and most active national market in the Asia Pacific region. Its dentists perform the highest number of dental implant procedures in the region, which increases the demand for dental biomaterials. The market for dental biomaterials in South Korea is fiercely competitive, with many local manufacturers developing lower cost dental biomaterial products, as well as large multinationals providing well-known trusted products. Both Japan and Australia lack such a variety of local competitors in terms of price levels and material makeup and have strict restrictions on the imports of dental biomaterials. Prices in those countries are twice what they are in South Korea. As a result, South Korean dentists are more likely to use the products and gain proficiency in them. As of 2012, South Korea represents approximately 70 percent of dental biomaterials revenues in the region.



Despite the restrictions it places on imports, the relatively underpenetrated Australian market is expected to grow faster than both Japan and South Korea through 2016, as international competitors seek areas of expansion. Nevertheless, Australia will remain the smallest of the three Asia Pacific markets.



"It takes a large initial investment to develop and offer a dental biomaterial product in the Asia Pacific region," said MRG Analyst Carmen Chan. "Regulatory processes are stringent and dentists are hesitant to adopt new products that are unfamiliar to them, which require potential competitors to invest in clinical studies and extensive marketing. As a result, leading competitors are large international companies, particularly Geistlich, which has a strong reputation and trusted relationships with dentists in Australia and South Korea. Geistlich registered in Japan at the end of 2011, and will grow further by entering that underpenetrated market."



Aside from Geistlich, competitors in the Asia Pacific region include Zimmer Dental, Oscotec, Impladent, Straumann and Riemser Arzneimittel.



Millennium Research Group's Asia Pacific Markets for Dental
Biomaterials 2012 report includes unit, average selling price and revenue information, along with market drivers and limiters and competitive landscape for bone graft substitutes, dental membranes and tissue regeneration products sold in Australia, Japan and South Korea.


Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo